Soujanya Sunkaraneni serves as the Vice president, Clinical Pharmacology at Hemab. She has over 17 years of progressive experience in clinical pharmacology, pharmacometrics, and drug development, with leadership roles across biotech and pharmaceutical companies, including Syndax, Takeda, Blueprint Medicines, and Sunovion Pharmaceuticals. Soujanya has led clinical pharmacology strategies,DMPK, bioanalysis, and modeling & simulation efforts to support global regulatory submissions and optimize drug development. Her expertise spans oncology, respiratory, neuroscience, and rare diseases. She holds an MS in Pharmacometrics from the University of Maryland and an MS in Pharmacology from St. John’s University.